Skip to content
healthcare.dev

Daptomycin

NDC 70594-060, daptomycin, injection, powder, lyophilized, for solution, from Xellia Pharmaceuticals USA LLC.

Product NDC
70594-060
Status
Listed
Labeler
Xellia Pharmaceuticals USA LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217415
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70594-060 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPTOMYCIN500 mg/10mL

Pharmacologic classes

Lipopeptide Antibacterial [EPC]; Lipopeptides [CS]

Package NDCNDC-11Package
70594-060-01705940060011 VIAL, SINGLE-USE in 1 CARTON (70594-060-01) / 10 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5e1f739a-eb81-43d8-9a14-89f32b7e1ba1
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70594-060

Use it

Look up 70594-060 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70594-060 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70594-060. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.